Revium Rx Company Description

Revium Rx, a pre-clinical stage biopharmaceutical company, develops nano-liposomal particles (NLP) based pharmaceutical candidates.

It develops nanoparticles-based formulation of a potent antibiotic; novel adjuvant for cancer therapies: and novel immunization based on liposomal protein-loaded technology.

The company was formerly known as Revium Recovery Inc. and changed its name to Revium Rx. in December 2024.

Revium Rx was incorporated in 1997 and is based in Herzliya, Israel.

Revium Rx

Country	United States
Founded	1997
Industry	Health Information Services
Sector	Healthcare
Employees	6
CEO	David Akunis

Contact Details

Address: 10 HaMenofim St Herzliya , Nevada 4672561 Israel
Phone	1-800-5191687
Website	reviumrx.com

Stock Details

Ticker Symbol	RVRC
Exchange	OTCMKTS
Fiscal Year	January - December
Reporting Currency	USD
ISIN Number	US76151C1009
SIC Code	2834

Key Executives

Name	Position
David Akunis L.L.M.	Chief Executive Officer
Inna Martin	President, Chief Operating Officer, Secretary and Director
Arie Gordashnikov CPA	Chief Financial Officer and Treasurer
Dr. Erez Koren	Chief Technology Officer